Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019
April 11, 2019 02:01 ET
|
Curetis
- Launched Unyvero System and Unyvero LRT Cartridge in the U.S. - Increased revenues to EUR 1.4 million in 2018 - Raised EUR 19.5 million additional funding - Revised focus and strategy ...
Curetis to Publish its Full-Year 2018 Financial Results on April 11, 2019
April 05, 2019 02:59 ET
|
Curetis
Company to host earnings conference call on same day Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 5, 2019, 08:00 am CET - Curetis N.V. (the "Company" and, together with its...
Curetis: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform
April 04, 2019 02:00 ET
|
Curetis
Growing body of evidence shows benefits of Unyvero for antibiotic stewardship8 new reports on European studies presented by clinical researchers using Unyvero HPN, ITI, BCU and IAI Amsterdam, the...
Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance
April 02, 2019 02:04 ET
|
Curetis
Knowledge base of antimicrobial resistance (AMR) markers tailored specifically to Unyvero ApplicationsDeveloped by Curetis’ subsidiary Ares Genetics and powered by ARESdbInitial focus on Unyvero...
Curetis To Attend Key Conferences in the Second Quarter of 2019
April 01, 2019 08:59 ET
|
Curetis
Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 1, 2019, 03:00 pm CET - Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a developer of next-level...
Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero
March 26, 2019 03:00 ET
|
Curetis
Menarini Diagnostics to distribute Unyvero Platform and application cartridges in numerous European countries Menarini Diagnostics to deploy its commercial team for the marketing of Unyvero...
Curetis’ Subsidiary Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance
February 18, 2019 16:05 ET
|
Curetis
QIAGEN becomes exclusive partner for bioinformatics research applications based on ARESdb and AREStoolsPartnership intends to create a community platform for antimicrobial resistance research ...
Curetis’ Partner Beijing Clear Biotech Submits Filing for Unyvero Approval in China
February 04, 2019 01:59 ET
|
Curetis
Curetis’ Partner Beijing Clear Biotech Submits Filing for Unyvero Approval in China Submission for Unyvero HPN Cartridge to Chinese regulatory authority NMPA includes U.S. and EU dataLeverages...
Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand
January 30, 2019 01:50 ET
|
Curetis
HPN Cartridge approved in Malaysia; HPN, BCU Cartridges approved in ThailandFurther commercial roll-out of Unyvero in ASEAN region by partner Acumen Research Laboratories facilitatedNear-term...
Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test
January 08, 2019 02:00 ET
|
Curetis
Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test Ares Genetics to start EUR 1.3 million TRIPLE-A development project co-funded by...